Actively Recruiting
Comparing Oral Nifedipine and Oral Labetalol for Treating High Blood Pressure After Delivery in Women
Led by Loma Linda University · Updated on 2026-02-04
500
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating oral Nifedipine versus oral Labetalol to see which is better at controlling high blood pressure in women after childbirth. This randomized control trial focuses on postpartum hypertension, a common condition affecting 10% of pregnancies and linked to serious health risks like stroke and heart disease. The study aims to compare these two medications, both considered safe, to determine the best choice for managing high blood pressure after delivery. Participants will receive either oral Nifedipine or oral Labetalol to control their blood pressure. Nifedipine dosing starts at 10mg three times daily and may be increased up to 120mg per day. Labetalol dosing begins at 200mg twice daily with possible increases up to 2400mg per day. Each participant will receive only one of these medications no experimental drugs or devices are used in this study. During the study, researchers will monitor participants for up to six weeks after delivery, assessing maternal health outcomes including hospital stay length and the need for additional blood pressure medication. Blood pressure readings and maternal complications will be tracked closely. Participants will have regular follow-ups to evaluate medication effects and safety throughout the postpartum period.
CONDITIONS
Brief Title
Safest Choice of Antihypertensive Regimen for Postpartum Hypertension
Research Team
A
Ashra Denise B Tugung, BSc
N
Nikia Gray-Hutto, RN, CCRP
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here